RATIONALE: Patients with obsessive compulsive disorder (OCD) demonstrate impaired cognition in some selected domains. Although serotoninergic dysfunction has been implicated in OCD, recent evidence suggests that dopamine may play a role as well. OBJECTIVE: The aim of the study was to evaluate learning and working memory in OCD and to determine the effects of dopaminergic manipulations on these capacities. METHODS:Visuospatial associative memory and spatial and verbal working memory were examined in 18 nondepressed patients with OCD and 18 matched healthy controls. The study further investigated whether acute administration of dopamine D2/D3 receptor agonist and antagonist would differentially modulate cognition in OCD. Each participant underwent the cognitive battery three times in a randomized double-blind, placebo-controlled crossover design. RESULTS: Significant impairments in patients compared with controls were noted on the Cambridge Neuropsychological Test Automated Battery (CANTAB) paired associates learning (PAL) and a measure of sustained attention (rapid visual information processing, RVIP) that persisted across all sessions, with deficient strategy in the CANTAB spatial working memory task in the first session alone. Although the dopamine D2/D3 agonist, pramipexole, led to poorer performance on the PAL and RVIP tasks, no differential effects were noted between the two groups. No significant effects were noted for the D2/D3 antagonist, amisulpride. CONCLUSIONS: The results are consistent with a specific associative memory deficit in OCD that remained robust despite possible practice effects and compensatory strategies and point to abnormal medial temporal lobe involvement in OCD in addition to the previously implicated frontostriatal loops, with no clear evidence of D2 receptor mediation.
RCT Entities:
RATIONALE: Patients with obsessive compulsive disorder (OCD) demonstrate impaired cognition in some selected domains. Although serotoninergic dysfunction has been implicated in OCD, recent evidence suggests that dopamine may play a role as well. OBJECTIVE: The aim of the study was to evaluate learning and working memory in OCD and to determine the effects of dopaminergic manipulations on these capacities. METHODS: Visuospatial associative memory and spatial and verbal working memory were examined in 18 nondepressed patients with OCD and 18 matched healthy controls. The study further investigated whether acute administration of dopamine D2/D3 receptor agonist and antagonist would differentially modulate cognition in OCD. Each participant underwent the cognitive battery three times in a randomized double-blind, placebo-controlled crossover design. RESULTS: Significant impairments in patients compared with controls were noted on the Cambridge Neuropsychological Test Automated Battery (CANTAB) paired associates learning (PAL) and a measure of sustained attention (rapid visual information processing, RVIP) that persisted across all sessions, with deficient strategy in the CANTAB spatial working memory task in the first session alone. Although the dopamine D2/D3 agonist, pramipexole, led to poorer performance on the PAL and RVIP tasks, no differential effects were noted between the two groups. No significant effects were noted for the D2/D3 antagonist, amisulpride. CONCLUSIONS: The results are consistent with a specific associative memory deficit in OCD that remained robust despite possible practice effects and compensatory strategies and point to abnormal medial temporal lobe involvement in OCD in addition to the previously implicated frontostriatal loops, with no clear evidence of D2 receptor mediation.
Authors: C S Peretti; J M Danion; F Kauffmann-Muller; D Grangé; A Patat; P Rosenzweig Journal: Psychopharmacology (Berl) Date: 1997-06 Impact factor: 4.530
Authors: L J Cohen; E Hollander; C M DeCaria; D J Stein; D Simeon; M R Liebowitz; B R Aronowitz Journal: J Neuropsychiatry Clin Neurosci Date: 1996 Impact factor: 2.198
Authors: Scott L Rauch; Michelle M Wedig; Christopher I Wright; Brian Martis; Katherine G McMullin; Lisa M Shin; Paul A Cannistraro; Sabine Wilhelm Journal: Biol Psychiatry Date: 2006-02-21 Impact factor: 13.382
Authors: Lara Menzies; Samuel R Chamberlain; Angela R Laird; Sarah M Thelen; Barbara J Sahakian; Ed T Bullmore Journal: Neurosci Biobehav Rev Date: 2007-10-17 Impact factor: 8.989
Authors: Rachel Marsh; Gregory Z Tau; Zhishun Wang; Yuankai Huo; Ge Liu; Xuejun Hao; Mark G Packard; Bradley S Peterson; H Blair Simpson Journal: Am J Psychiatry Date: 2014-12-19 Impact factor: 18.112
Authors: Pietro Cipresso; Filippo La Paglia; F L Paglia; Caterina La Cascia; C L Cascia; Giuseppe Riva; Giovanni Albani; Daniele La Barbera Journal: Exp Brain Res Date: 2013-03-28 Impact factor: 1.972
Authors: Susanne E Ahmari; Teal Eich; Deniz Cebenoyan; Edward E Smith; H Blair Simpson Journal: Neurobiol Learn Mem Date: 2014-06-30 Impact factor: 2.877
Authors: Paula Banca; Martin D Vestergaard; Vladan Rankov; Kwangyeol Baek; Simon Mitchell; Tatyana Lapa; Miguel Castelo-Branco; Valerie Voon Journal: Neuropsychopharmacology Date: 2015-03-13 Impact factor: 7.853